1. Introduction {#s0005}
===============

Recent reports have described a secondary Multisystem Inflammatory Syndrome in Children (MIS-C) after a prior COVID-19 infection, who have presented with features of Kawasaki disease (KD) \[[@bb0005],[@bb0010]\]. Recently, there are media reports of young adults in their late teens and early twenties with the same syndrome \[[@bb0015]\]. The following case describes the clinical features, treatment, and response of an adult who presented with a KD-like inflammatory disorder, similar to past reports of MIS-C, with evidence of a prior COVID-19 infection.

2. Case description {#s0010}
===================

A 36-year-old previously healthy Hispanic female presented to the hospital with 1 week of subjective fevers, abdominal pain, vomiting, and diarrhea with 2 days of a diffuse rash and arthralgias. The patient presented to the Emergency Department febrile, tachycardic, tachypneic, hypotensive and with the classic phenotype of complete Kawasaki\'s Disease \[[@bb0020]\]: Bilateral nonexudative conjunctivitis ([Fig. 1](#f0005){ref-type="fig"}A); mucositis with cracked lips ([Fig. 1](#f0005){ref-type="fig"}B); edema of the bilateral hands and feet ([Fig. 1](#f0005){ref-type="fig"}C, 1D); palmar erythema ([Fig. 1](#f0005){ref-type="fig"}D); a diffuse maculopapular rash ([Fig. 1](#f0005){ref-type="fig"}E); and cervical lymphadenopathy. The constellation of findings was suspicious for Kawasaki Disease Shock Syndrome (KDSS) \[[@bb0025]\].Fig. 1Features of Kawasaki Disease -- nonexudative conjunctivitis with heliotrope rash (1A), mucositis with cracked lips (1B), extremity edema (1C, 1D), palmar erythema (1D), diffuse maculopapular rash (1E).Fig. 1

Laboratory results included leukocytosis with WBC of 25.3 K/UL (4.9--10.8), absolute neutrophilia of 19.5 K/UL (1.4--6.5) without significant lymphopenia (absolute lymphocytes 1.1 K/UL \[1.2--3.4\]), mild normocytic anemia (Hgb 10.8 g/dL \[12--16\]), and normal platelets. The patient had hyponatremia of 115 mmol/L (133--146), and abnormal LFTs with AST 81 IU/L (10−33), ALT 116 IU/L (6--47), ALP 311 IU/L (36--112), direct hyperbilirubinemia (total bilirubin 3.9 mg/dL \[0.2--1.4\], direct bilirubin 2.4 mg/dL \[0.0--0.2\]). Serum albumin was decreased at 2.5 g/dL (3.5--5.2) and INR increased to 2. ESR was 30 mm/h (0−20), CRP: 30 mg/dL (0.0--0.9), and d-dimer: 652 ng/mL (\<318). ANA was 1:160 (\<1:80), SSA was 2.8 (\<0.9), with C3 of 59 mg/dL (81--157) and C4 of 12 mg/dL (13--39); however anti-dsDNA, anti-smith, anti-RNP, SSB, RF, CCP, ANCA, ASO, and anti-Jo-1 antibodies were negative. HIV and hepatitis panels were negative. A bedside right upper quadrant ultrasound revealed mild gallbladder wall edema. CT angiogram of the chest revealed normal lung parenchyma and a trace right pleural effusion. CT abdomen/pelvis illustrated mild circumferential gallbladder wall thickening and a small area of colitis; all of which have been seen in KD and previously reported in MIS-C \[[@bb0005]\]. Echocardiogram after treatment with IVIG revealed an EF of 65% with moderate tricuspid valve regurgitation. Subsequent CTA coronaries was normal except for a trace pericardial effusion. COVID-19 testing revealed positive PCR, as well as a positive IgG with negative IgM antibodies.

Treatment was initiated with fluid resuscitation for shock, a single dose of aspirin 650 mg, IVIG 2 g/kg, and methylprednisolone 2 mg/kg for 5 days followed by a prednisone taper. The patient experienced a near resolution of symptoms and normalization of vital signs within 1 day. Inflammatory markers and hyperbilirubinemia improved rapidly over 6 days. AST, ALT, and ALP initially rose but trended down during this time. The patient was discharged home on prednisone.

3. Discussion {#s0015}
=============

This case represents an early report of a KD-like illness in an adult with serologic evidence of a previous COVID-19 infection, similar to MIS-C. KD is a rare illness in pediatrics and even more rare in adults. However, the virulent strain of SARS-CoV-2 appears to cause a post-infectious inflammatory syndrome similar to KD in both the pediatric and adult populations. While our patient met criteria for KD, there are inconsistent features such as a heliotrope rash with prominent plate-like scaling ([Fig. 1](#f0005){ref-type="fig"}A) and hypocomplementemia. Repeat ANA and SSA antibodies will be needed to determine persistence. These low titers do not appear consistent with her presentation and may be clinically insignificant.

4. Conclusion {#s0020}
=============

Our understanding of the myriad of COVID-19 symptoms and sequelae is rapidly evolving. We recommend physicians remain vigilant for secondary inflammatory syndromes that mimic KD/KDSS which may warrant prompt treatment with IVIG and steroids.
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